Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients

[11] Weidle UH(2008)Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer Breast Cancer Res Treat 112 419-427

[12] Bloemers HP(2010)ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer J Surg Oncol 101 564-569

[13] Figdor CG(2007)The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells Mol Cancer Res 5 1246-1253

[14] Swart GW(2009)Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer Int J Cancer 125 9-14

[15] Dalerba P(2006)REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229-235

[16] Dylla SJ(1987)Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 138-140

[17] Park IK(2011)Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer BMC Cancer 11 12-409

[18] Liu R(2006)Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 59 403-1733

[19] Wang X(2008)Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin Cancer Res 14 1726-2105

[20] Cho RW(2009)Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients Int J Cancer 124 2098-464

[11] Weidle UH(2008)Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer Breast Cancer Res Treat 112 419-427

[12] Bloemers HP(2010)ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer J Surg Oncol 101 564-569

[13] Figdor CG(2007)The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells Mol Cancer Res 5 1246-1253

[14] Swart GW(2009)Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer Int J Cancer 125 9-14

[15] Dalerba P(2006)REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229-235

[16] Dylla SJ(1987)Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 138-140

[17] Park IK(2011)Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer BMC Cancer 11 12-409

[18] Liu R(2006)Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 59 403-1733

[19] Wang X(2008)Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin Cancer Res 14 1726-2105

[20] Cho RW(2009)Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients Int J Cancer 124 2098-464